Comparison of Community- and Health Care - Associated Methicillin-Resistant Staphylococcus aureus Infection

Journal of the American Medical Association

Volumn 290, Issue 22, 2003, Pages 2976-2984

  Naimi, Timothy S ^a,d,e   LeDell, Kathleen H ^a   Como Sabetti, Kathryn ^a   Borchardt, Stephanie M ^a   Boxrud, David J ^a   Etienne, Jerome ^b   Johnson, Susan K ^a   Vandenesch, Francois ^b   Fridkin, Scott ^c   O'Boyle, Carol ^a   Danila, Richard N ^a   Lynfield, Ruth ^a  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

^b Fr Ref Centre for Staphylococci   (France)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Division of Reproductive Health   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; EXOTOXIN; GENTAMICIN; MACROLIDE; METICILLIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLINICAL LABORATORY; COMMUNITY; HOSPITAL; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINNESOTA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0344738732     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.22.2976     Document Type: Article

References (40)

1. Barrett FF, McGehee RF, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. N Engl J Med. 1968;279:441-448.
2. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis. 1998;26:1179-1181.
3. Jorgensen JH. Laboratory and epidemiologic experience with methicillin-resistant Staphylococcus aureus in the USA. Eur J Clin Microbiol. 1986;5:693-696.
4. Kreiswirth B, Kornblum J, Arbeit RD, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science. 1993;259:227-230.
5. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520-532.
6. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med. 1989;320:1188-1196.
7. Centers for Disease Control. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA. 1999;282:1123-1125.
8. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA. 2001;286:1201-1205.
9. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-aquired methicillin-resistant Staphylococcus aureus infections in Minnesota, 1996-1998. Clin Infect Dis. 2001;33:990-996.
10. Fey PD, Said-Salim B, Rupp ME, et al. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003;47:196-203.
11. Leman RF, Alvarado F, Kuehnert M, et al. CA methicillin-resistant Staphylococcus aureus nasal carriage among an American Indian population. In: 51st Annual Epidemic Intelligence Service Conference; April 22-26, 2002; Atlanta, Ga.
12. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593-598.
13. Frank AL, Marcinak JF, Mangat PD, Schreckeberger PC. Comunity-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J. 1999;18:993-1000.
14. Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J. 1999;18:410-414.
15. Siegel JD, Cushion NB, Roy LC, Krisher KK. Community-acquired (CA) methicillin resistant Staphylococcus aureus (MRSA) infections in children. Paper presented at: 37th Annual Meeting Infectious Disease Society of America, November 18-21, 1999; Philadelphia, Pa
16. Adcock PM, Pastor P, Medley F, Patterson JE, Murphy TV. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis. 1998;178:577-280.
17. Embil J, Ramotar K, Romance L, et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol. 1994;15:646-651.
18. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med. 1999;153:864-868.
19. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2003;52:88.
20. Performance Standards for Antimicrobial Susceptibility Testing: Ninth Information Supplement. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1999.
21. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 4th ed. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1997.
22. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
23. Nishi J, Miyanohara H, Nakajima T, Kitajima I. Molecular typing of the methicillin resistance determinant (mec) of clinical strains of Staphylococcus based on mec hypervariable region length polymorphisms. J Lab Clin Med. 1995;126:29-35.
24. Jaaud S, Mougel C, Thioulouse J, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles) and human disease. Infect Immun. 2002;70:631-641.
25. Oliveira D, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:2155-2161.
26. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-1132.
27. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis [serial online]. August 2003. Available at: http://www.cdc.gov/ncidod/EID/vol9no8/03-0089.htm.
28. Zhang J, Yu KF. What's the relative risk? JAMA. 1998;280:1690-1691.
29. Wielders CL, Vriens MR, Brisse S, et al. In-vivo transfer of mecA DNA to Staphylococcus aureus. Lancet. 2001;357:1674-1675.
30. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-1827.
31. Johnson L, Bhan A, Pawlak J, Manzor O, Saravolatz LD. Changing epidemiology of community-onset methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2003;24:431-435.
32. Jernigan JA, Pullen AL, Partin C, Jarvis WR. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infect Control Hosp Epidemiol. 2003;24:445-450.
33. Charlebois E, Bangsberg D, Moss N, Moore M, Moss A, Chambers HF. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 2002;34:425-433.
34. Gillet Y, Issartel B, Vanhems P. Association between Staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin and hightly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753-759.
35. Etienne J, Vandenesch F, Lina G, Berchiche C, Naimi T, Nimmo G. Role of Panton Valentine leukocidin in community-acquired infections due to methicillin-resistant Staphylococcus aureus. Paper presented at: 10th International Symposium on Staphylococci and Staphylococcal Infections; June 2-5, 2002; Tsukuba, Japan.
36. Baggett HC, Hennessy TW, Leman R, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol. 2003;24:397-402.
37. Torvaldsen S, Roberts C, Riley TV. The continuing evolution of methicillin-resistant Staphylococcus aureus in western Australia. Infect Control Hosp Epidemiol. 1999;20:133-135.
38. Frank AL, Marcinak JF, Mangat D, Schreckenberger PC. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis. 1999;29:935-936.
39. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178-182.
40. Boyce JM. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? JAMA. 1998;279:623-624.